MIAMI and HAIFA, Israel, Feb. 4, 2021 /PRNewswire/ — Insightec, a global healthcare company focused on creating the next generation of patient care, today announced that it has received FDA IDE approval to conduct a pivotal study to evaluate staged, bilateral Focused Ultrasound treatment of patients with medication-refractory Essential Tremor.

Read more here.